Research is being conducted on the effectiveness of combining chemotherapy with bevacizumab and immunotherapy in treating colorectal cancer. Studies and trials are exploring the efficacy and safety of various immunotherapy approaches, including checkpoint inhibitors, in different types of cancer. The outcomes of these studies may have implications for the treatment of colorectal cancer and other cancers, but the specific findings and results are not consistently reported across the available headlines.